Abstract
A novel method is described for the immobilization of alcohol dehydrogenase (ADH) from Saccharomyces cerevisiae onto carboxymethyl dextran (CMD) coated magnetic nanoparticles (CMD-MNPs) activated with epoxy groups, using epichlorohydrin (EClH). EClH was used as an activating agent to bind ADH molecules on the surface of CMD-MNPs. Optimal immobilization conditions (activating agent concentration, temperature, rotation speed, medium pH, immobilization time and enzyme concentration) were set to obtain the highest expressed activity of the immobilized enzyme. ADH that was immobilized onto epoxy-activated CMD-MNPs (ADH-CMD-MNPs) maintained 90% of the expressed activity. Thermal stability of ADH-CMD-MNPS after 24 h at 20 °C and 40 °C yielded 79% and 80% of initial activity, respectively, while soluble enzyme activity was only 19% at 20 °C and the enzyme was non-active at 40 °C. Expressed activity of ADH-CMD-MNPs after 21 days of storage at 4 °C was 75%. Kinetic parameters (KM, vmax) of soluble and immobilized ADH were determined, resulting in 125 mM and 1.2 µmol/min for soluble ADH, and in 73 mM and 4.7 µmol/min for immobilized ADH.
Similar content being viewed by others
Introduction
In modern green chemistry, enzymes are valuable natural biocatalysts that possess some excellent properties, such as high activity, high selectivity and specificity, that allow even the most complex chemical reactions to be performed under mild experimental conditions1,2,3,4. Therefore, enzymes can find applications in various industrial processes and fields, such as biomedicine, nanotechnology, pharmaceuticals, biosensors, protein engineering, etcetera, and the main reason for such a wide application range is the enzyme stability. However, free enzymes are usually not stable in buffer solutions, but after immobilization (via covalent attachment, encapsulation, or simple adsorption), their stability can improve drastically5,6,7,8,9,10,11,12. Immobilization is a simple solution to many free enzyme related problems. Enzyme immobilization improves the controlling nature of the enzyme and eliminates many limitations by improving enzymes’ stability, selectivity or specificity, and even reduces enzyme inhibition13,14. Different supports may be applied using reversible methods, such as physical immobilization, and irreversible methods, such as covalent coupling15,16,17. Such immobilization protocols may even be applied to membrane technology for biocatalytic removal of pollutants18. Improving enzyme stability is one advantage of enzyme immobilization, since reusability of an enzyme is only possible when the activity of the enzyme can be maintained for several reaction cycles. However, not all immobilization methods are appropriate, nor do they all improve enzyme stability. If a less suitable immobilization method is used on the wrong support, this can even decrease the stability of an enzyme. Stability of an enzyme can also be improved by multipoint covalent attachment via short spacer arms that are attached on pre-existing rigid supports. For such immobilization, it is crucial to select an appropriate support, along with suitable reactive groups and immobilization conditions. Such supports have to present many reactive groups and offer low steric hindrances. Multipoint covalent attachment might be achieved using epoxides19, amino groups activated with glutaraldehyde20 or glyoxyl21 supports. While using non-porous supports, the specific area of such supports must be considered, since it depends on the particle size, which has to be in nano-scale in order to support reasonable enzyme loading capacity14,22. Enzymes immobilized onto non-porous materials can be attached to the support by multipoint in order to increase stability, as long as the enzyme is properly oriented on the surface of the support, while such multipoint attachments are not possible on a porous support. Nevertheless, there are some drawbacks to such immobilization onto an external surface, such as the non-protection of the enzyme from hydrophobic interfaces (in the form of gas bubbles). Also, proteolysis might occur, since enzyme molecules from one particle can interact with enzyme molecules from another particle. This can be improved by coating the support with polymers that prevent interactions and avoid enzyme inactivation. Another drawback involves diffusion limitations, which can decrease the expressed activity of enzymes, or even the stability of an enzyme23,24. Multipoint or multisubunit (in multimeric enzymes) immobilization can improve the rigidity of an enzyme and therefore improve its stability1,4,25. In addition, some immobilization strategies even provide the immobilization of an enzyme together with its purification in just one process step, without losing potential improvements to the enzyme. In industry, purified enzymes are expensive, which is the reason that only partially purified enzymes are used14,25. Also, enzyme selectivity and specificity can be improved by immobilization methods. However, since immobilization protocols may alter enzyme structure by changing the rigidity of specific areas or even changing the features of the enzyme, enzyme specificity and selectivity might change, as well. This change appears in the form of decreased or increased specificity and selectivity of the enzyme. In some cases, enzyme selectivity and specificity changes make an enzyme highly selective towards one specific enantioisomer or highly selective to another isomer. On the other hand, if free enzymes already have suitable properties, only a moderate immobilization should be applied to preserve such properties. In such cases, one-point covalent immobilization offers a better solution as an immobilization strategy14,26,27. Enzyme inhibition presents a problem in some reactions, since substrates, products or other compounds may cause a reduction in the reaction rate or even stop the reaction itself. Immobilization can be a solution to such problems, since enzymes that are being immobilized can increase their inhibitory constant (Ki), which consequently affects their KM. With this cause, the enzyme inhibition is being reduced on the reaction course. Another effect is possible when the immobilization protocol blocks the enzyme inhibition site and therefore prevents enzyme inhibition14.
Iron oxide nanoparticles used as nano-carriers for enzyme immobilization represent a promising system in bionanomedicine, which has numerous clinical applications, such as cell targeting and labelling, targeted drug delivery, tissue repair and in biosensors28,29,30,31,32,33. When different magnetic nanoparticles (MNPs) were applied in a biosensor application, an amperometric biosensor was based on polydopamine-coated magnetite nanoparticles, which was used as a platform for the immobilization of glucose oxidase, alcohol oxidase and cholesterol oxidase, which were used to detect biomolecules34. Another study involves the synthesis of magnetite/lignin (Fe3O4/Lig) and magnetite/lignin/polydopamine (Fe3O4/Lig/PDA) materials, which were used for the immobilization of glucose oxidase, which can be applied in a biosensing application35. Magnetic nanoparticles (MNPs) have unique properties, such as superparamagnetism, large surface area and low toxicity30,36,37,38,39,40,41. However, they are inclined to aggregate, because of their strong magnetic dipole42,43. Since there are not enough active groups on the surface of nanoparticles, except for a few hydroxyl groups, their modification is in place. To overcome these restrictions and to make nanoparticles more biocompatible and biodegradable with low toxicity, various methods to functionalize the surface of MNPs using different organic polymers are employed to prevent degradation of iron oxide nanoparticles44,45,46,47,48. One such suitable organic polymer is dextran, which is a biocompatible, water-soluble, branched polysaccharide, made of many glucose molecules, comprising α-1, 6-glycosidic linkages and mostly used for health care products, including MRI and hyperthermia agents49,50,51. Dextran is produced by dextransucrases of various origins and has relatively high water solubility, high stability in both acidic and basic conditions and a large amount of hydroxylic groups. All these properties make dextran an excellent material for various kinds of chemical and physical cross-linking. There is an extensive review of dextran in biocatalysis, where it is described as an important and effective immobilization system52. A study by Shaterabadi et al. shows that the presence of dextran in a reaction medium results in significant suppression of the saturation magnetization of dextran-coated nanoparticles. Moreover, biocompatibility studies reveal that surface modification of nanoparticles by dextran coating decreases the cytotoxicity of uncoated nanoparticles and therefore improves their potential applications in biomedicine53. It has also been shown that dextran coating decreases iron nanoparticle-mediated cytotoxicity in pulmonary artery cells54, while another study shows that dextran-coated nanoparticles have no significant effect on synaptic vesicular functions55. There are also some acute toxicity and irritation studies, where the cytotoxicity of dextran-coated nanoparticles is attributed to the breakdown of the dextran shell exposing bare iron oxide nanoparticles, which interact with cellular systems56. Modified MNPs are usually further functionalized using different functionalization groups. The epoxy-activated group is a very active group, which can react with proteins, enzymes and nucleic acids, resulting in beneficial immobilization of biomolecules. Epoxy groups are also very stable at neutral pH values; therefore, different commercial supports can be prepared at a far position, where the enzyme has to be immobilized, which means epoxy-activated supports are very suitable biological systems to develop easy enzyme immobilization protocols57,58. EClH is a chlorinated epoxy compound and an epoxide, which is metabolized by binding to glutathione and by hydration via epoxide hydrolase with bifunctional alkylating activity. It is routinely used in the production of numerous synthetic materials, including epoxy, phenoxy and polyamide resins, cross-linked starch, surfactants and other pharmaceutical products59,60,61. However, immobilization onto epoxy-activated supports takes place in a two-step mechanism. In the first step, the adsorption of the enzyme is promoted, which means that the proposed immobilization on such support includes the usage of high ionic strength, which forces hydrophobic adsorption of the enzyme. In the second step, the enzyme that is adsorbed is covalently attached to the activated epoxy groups that are present on the surface of the support57. Two studies describe epoxy-functionalized nanoparticles, which were modified with silica, as a support for the immobilization of horse liver ADH to be a suitable carrier for immobilization of enzymes62,63, while another study shows immobilization of a lipase from porcine pancreas being covalently immobilized on the magnetic microspheres via the active epoxy groups64. There is also a study describing lipase immobilization onto epoxy-functionalized silica nanoparticles65 and another describing laccase immobilization onto epoxy-functionalized chitosan magnetic beads66. All reported studies show the importance and significance of epoxy-functionalized nanoparticles, suitable for enzyme immobilization.
In our study, we immobilized the enzyme ADH from S. cerevisiae, which is an important biological catalyst for oxidation of alcohols and reduction of aldehydes or ketones67,68,69,70,71. Therefore, ADH has many potential applications in various chemical industries, such as the pharmaceutical and food industry. It is important because of its yield and versatility in redox reactions72,73,74. Because of its enantioselectivity, it is an excellent catalyst in the pharmaceutical industry, since it can produce high-value enantiopure drugs75,76. ADH also has great application for production of various starting materials and intermediates, and synthesis of chiral compounds, but mainly for regeneration of the coenzymes NAD(P) and NAD(P)H. It has been applied in biosensor technology, as well77,78,79,80. However, ADH has low stability, which limits its use in industrial applications81, owing to its high sensitivity to temperature and pH. When applied under alkaline conditions, ADH’s tertiary structure distorts; when applied under acidic conditions, multimeric subunits of ADH dissociate, both of which cause the loss of ADH activity82,83,84,85,86. In order to stabilize and obtain the tertiary structure of such multimeric enzymes, an immobilization protocol of a multisubunit attachment to a very rigid support can be applied. Such an immobilization strategy requires that some of the crucial parameters be controlled (in general all parameters that play a role in improving the expressed activity of an immobilized enzyme, e.g. temperature, pH, immobilization time, enzyme concentration etc.). However, immobilizing under optimal conditions does not always guarantee fully stabilisation of the tertiary structure of multimeric enzymes, since the subunits might not be in the same place, making it impossible to perform stabilisation of an enzyme via the immobilisation protocol. In such a case, the enzyme will release the subunits into the reaction medium and become deactivated87.
There are studies describing immobilization of liver horse ADH inside porous supports88, while others show covalently immobilized ADH onto MNPs via a glutaraldehyde coupling reaction, where it managed to retain 49% of its original activity89. Later, there was a study describing immobilization of ADH developed by using surface functionalization of chitosan-coated MNPs, which retained 65% of its original activity44. More recent studies investigate immobilization of ADH on agarose activated with glyoxyl groups in the presence of acetyl cysteine, which results in 25% of expressed activity85. Anther research report describes immobilization of ADH onto silica nanoparticles functionalized with amino, epoxy and thiol groups, where a decrease of 60–70% in specific activities was observed62. Moreover, immobilization via covalent binding on crystalline Ni–Co nanoferrites, synthesized via sol–gel auto combustion techniques, was investigated, resulting in 40% expressed activity of immobilized ADH90. Immobilization of ADH onto polyaniline-coated silver nanoparticles, where it maintained 73% of the initial activity91, was also reported. However, there is a study describing immobilization of ADH onto epoxy-functionalized silica coated MNPs, where expressed activity of 92% was maintained at pH 8 and 30 °C with a 12-h immobilization time63, which proves the beneficial advantage of epoxy-functionalized nanoparticles for ADH immobilization. In comparison, our study proved better thermal stability of immobilized ADH, since it retained 80% of its initial activity after 24 h at 40 °C, while soluble ADH was inactivated under the same conditions.
There are many research reports describing immobilization methods for binding different protein molecules to different dextran-coated MNPs92,92,93,94,95,96,97. There are also studies describing the use of CMD-MNPs in various applications98,99,100,101,102. However, there are only a few that describe the activity of ADH being affected by using different dextrans103,104,105, and none reporting about immobilization of ADH onto CMD-MNPs via epoxy activation, which makes our study a novelty. In this study, CMD-MNPs were prepared and later epoxy activated with the epoxide EClH as an activating agent, to be used as a carrier for immobilization of ADH. Thus, it is a novel method for immobilization of ADH onto CMD-MNPs via epoxy activation in a two-step mechanism. The overall idea of our study in presented in Fig. 1. The process factors (EClH concentration, temperature, rotation speed, medium pH, immobilization time and enzyme concentration) were optimized to obtain the highest expressed activity and immobilization yield of the immobilized ADH-CMD-MNPs. Characterization of the prepared nano-carrier CMD-MNPs and immobilization of ADH onto non-activated CMD-MNPs was published in our previous work106, while in this study, detailed characterization of immobilized ADH-CMD-MNPs was performed, while investigating its morphology and structure using FT-IR, TGA, SEM and DLS.
A schematic overall idea of our proposed manuscript describing immobilization of ADH onto epoxy activated CMD-MNPs via two-step mechanism; optimization of process parameters performed in single-factor experiments and the characterization of prepared biocatalyst (ADH-CMD-MNPs).
Results and discussion
Preparation and activation of ADH-CMD-MNPs
CMD-MNPs were synthesized by the co-precipitation method as described in our previously published article106. Subsequently, 20 mg of CMD-MNPs were activated with epoxy groups, using EClH, which was used as an agent for activating the ADH enzyme molecules and the CMD-MNPs. A specific volumetric ratio (% (v/v)) of EClH was used, and 0.1 M sodium phosphate buffer (pH 7.5) was added so that the final volume was 1 mL. Since EClH was incubated with CMD-MNPs and ADH, this resulted in the formation of an activated matrix of the enzyme and CMD-MNPs. ADH was immobilized via covalent binding between epoxy groups of CMD-MNPs and hydroxyl groups of ADH, which can also be observed from FT-IR spectra. It is well known that EClH can covalently bind amino (–NH2), sulfhydryl (–SH) and hydroxyl (–OH) moieties on proteins107.
Immobilization of ADH-CMD-MNPs
Effects of process parameters on ADH immobilization
The concentration of EClH was optimized by performing immobilization of ADH on CMD-MNPs with different volumetric ratios of 0.5 M EClH as an activating agent, ranging from 2% (v/v) to 8% (v/v) with a final volume of 1 mL using a sodium phosphate buffer (pH 7.5). The activation was performed for 1 h at 300 rpm at 20 °C. After 1 h, the enzyme ADH (7.4 U) with additional sodium phosphate buffer (pH 7.5) in a volumetric ratio 1:9 (final volume 1 mL) was added to the activated CMD-MNPs, so that the final volume of the enzyme was 0.02 mg/mL. The immobilization was performed for 2 h at 400 rpm and 4 °C. Enzyme expressed activity was determined with the help of an enzymatic assay for ADH determination, using ethanol as a substrate, and immobilization yield was determined by estimating the protein concentration with the Bradford method in supernatants after immobilization and twice-repeated washing of the immobilized ADH-CMD-MNPs. As shown in Fig. 2a, when applying 2% (v/v) of EClH, the expressed activity was very low, only 19%. This could suggest that low activating agent concentration yields poor mechanism strength, easily leading to leaching of the enzyme from the carrier support. By increasing the concentration of the activation agent EClH to 4% (v/v), the expressed activity began to increase and proved to be the optimal volumetric concentration, since it retained 88% of the original enzyme activity, which corresponds to 6.5 U/mL. With increasing activating agent concentration, the number of free active groups on the surface of the carrier resulted in higher ADH loading, causing higher expressed activity of immobilized ADH. Also, immobilization yield was very high, resulting in 100%. In this case, immobilization yield goes hand-in-hand with the expressed activity of ADH. With further increasing the concentration of EClH, expressed activity and enzyme immobilization yield began to decrease. At 6% (v/v) of EClH, expressed activity decreased drastically to 38% and even more when applying 8% (v/v) of EClH, which resulted in 21% activity. This suggests that the limit of activation had been reached. Too high a concentration of the activating agent can result in enzyme deactivation, as well as in loss of activity, because excess concentrations of the activating agent result in blocking of the enzyme active groups108. Immobilization yield was 89% for 8% (v/v), 94% for 6% (v/v) and 94% for 2% (v/v) of used EClH. Immobilization of ADH onto non-activated CMD-MNPs was described in our previously published article106, where no activation of support with EClH was performed. Immobilization was performed at two different temperatures, 4 °C and 20 °C, and resulted in only 26% and 15% of expressed activity of immobilized ADH, respectively. This study shows that activating the support with epoxy groups significantly improves the expressed activity of immobilized ADH. The 62% increase in expressed activity of immobilized ADH resulted in 88% of expressed activity of immobilized ADH onto epoxy-activated CMD-MNPs.
Expressed activity and immobilization yield of ADH-CMD-MNPs with the change in EClH concentration, immobilization temperature, rotation speed and pH value of immobilization medium. (Standard deviation for all samples was less than 2%; constant process conditions available in Table 2).
The temperature at which the immobilization is performed is an important factor affecting expressed enzyme activity and immobilization yield, as well as the operational nature of the immobilized enzyme. The immobilization protocol was performed using an optimized volumetric ratio of EClH for activation of CMD3-MNPs from the first optimization step, which was 4% (v/v) with a 0.1 M sodium phosphate buffer (pH 7.5). Immobilization was performed for 2 h at 400 rpm with an enzyme concentration of 0.02 mg/mL, varying the immobilization temperature, which was 4 °C, 20 °C, 30 °C and 40 °C. The effect of immobilization temperature is presented in Fig. 2b, where it can be observed that the highest expressed activity was maintained at 4 °C, resulting in 57%. Immobilization yield reached 81%. At a lower immobilization temperature, the enzyme acts in a more stable manner and yields high immobilization yield, which can be used in further optimization protocols; it also offers broad possibilities in various applications. Immobilization performed at 20 °C, 30 °C and 40 °C resulted in a decrease in expressed activity (39%, 37% and 40%, respectively), with immobilization yield figures of 97%, 77% and 43%, respectively.
Another important factor influencing the expressed activity of immobilized enzymes is rotation speed, where high rotation speed preferably results in higher expressed activity, since the bond between epoxy-activated MNPs and the enzyme is stronger and therefore more successful, as it allows more contact between the enzyme and the support109. When optimizing the rotation speed of immobilization, the same conditions were used as those for activation of CMD-MNPs, which were 4% (v/v) of EClH with a sodium phosphate buffer (pH 7.5) and a duration of 1 h at 300 rpm and 20 °C. When performing immobilization for 2 h, an enzyme concentration of 0.02 mg/mL was applied and the optimal temperature from the previous step, which was 4 °C at different rotation speeds (200 rpm, 400 rpm and 500 rpm), which were studied in order to obtain the highest expressed activity of immobilized ADH. As can be seen from our results in Fig. 2c, when applying 200 rpm to the immobilization process, only 56% of expressed activity was maintained. After doubling the rotation speed to 400 rpm, the expressed activity slightly increased to 59%. With a further increase in rotation speed to 500 rpm, the highest expressed activity was maintained, resulting in 88%, but at these conditions, a drop in immobilization yield was observed. Immobilization yield was 100% for 200 rpm and 400 rpm, but a slight decrease is observed at 500 rpm, resulting in still value (90%). The reason for the slight drop in immobilization yield can be the stronger shear forces occurring in the immobilization process at higher rotation speeds110,111, which on the other hand, did not affect the enzyme’s expressed activity.
Enzyme action and the properties of the immobilized enzyme are strongly influenced by the surrounding micro-environment in which the immobilization process is performed. An important parameter in this case is the pH of the immobilization medium. The pH of the solution also dictates the amount of enzyme loaded to the surface of the carrier by altering the electronic properties of the enzyme and the carrier. Each enzyme has its own optimal pH, as does ADH from S. cerevisiae, for which it is in the pH range 5–9112. Thus, ADH was immobilized under different pH conditions in the range from 5 to 9, using all previously optimized conditions for activation of CMD-MNPs and immobilization of the enzyme ADH, which were 4% (v/v) of EClH, 300 rpm and 20 °C. The immobilization protocol lasted for 2 h at 4 °C and 500 rpm with 0.02 mg/mL enzyme concentration, varying the pH of the immobilization medium. As seen from the results in Fig. 2d, the highest expressed activity was observed in pH medium 7.5 (87%). Expressed activity of immobilized ADH began to decrease the closer it approached to a more alkaline or more acidic micro-environment. Protein denaturation may occur under conditions of excess alkali or acid113; that is why it is important to select an appropriate pH value for the immobilization procedure. The lowest expressed activity was reached at the most acidic pH value (pH 5), 14% with an immobilization yield of 28%. In addition, the most alkaline pH value (pH 9) also resulted in a significant loss of enzyme activity to only 25%, with an immobilization yield of 94%. When a multimeric enzyme such as ADH is applied under acidic conditions, its multimeric subunits dissociate. Furthermore, when applied under alkaline conditions, its tertiary structure distorts, both of which cause a loss of its activity87.
Nevertheless, when immobilizing such an enzyme on an epoxy-activated support, the immobilization involves a two-step mechanism57. First, the functional groups of the enzyme ADH are adsorbed on the surface of an epoxy-activated support, such as epoxy-activated CMD-MNPs. Second, the enzyme ADH that is adsorbed becomes covalently attached to the epoxy-activated support of CMD-MNPs.
The influence of immobilization time is presented in Fig. 3a. At first, immobilization time expanded over the period of 24 h; during optimization the time shortened gradually to 2 h, while using all optimized conditions from previous steps for activation of CMD-MNPs, using 4% (v/v) of EClH for 1 h at 20 °C and 300 rpm, and all conditions for immobilization, which was performed at 4 °C in pH 7.5 at 500 rpm with 0.02 mg/mL of ADH, varying the time of immobilization. At the longer immobilization time of 24 h, the expressed activity of immobilized ADH-CMD-MNPs maintained only 36%, with 76% of immobilization yield. When performing the immobilization for only 12 h, the expressed activity resulted in a slight increase, exhibiting 37% of expressed activity and 96% of immobilization yield. After splitting the duration of immobilization in half again, the expressed activity increased a bit further, resulting in 45% after 6 h, with 90% of immobilization yield. When the immobilization time was only 3 h, the expressed activity significantly increased and exhibited 70%, with 97% of immobilization yield. After another cut in immobilization time, the highest expressed activity of immobilized ADH-CMD-MNPs was maintained after just 2 h, resulting in 87%, with 100% of immobilization yield. The results indicate that the immobilization time has an important effect on the expressed activity of immobilized ADH-CMD-MNPs and that the optimal immobilization lasts for 2 h, which is sufficient time to bind the enzyme ADH effectively to the CMD-MNP surface with its highest possible activity. Since each enzyme has its own specificity, the immobilization time is of high importance. When the carrier is saturated with the enzyme on its surface and all active sites on the enzyme are occupied, the immobilization process of the enzyme onto the carrier stops. This can be exhibited in the form of lower expressed activity of the immobilized ADH.
Expressed activity and immobilization yield of ADH-CMD-MNPs at different immobilization times and different enzyme concentrations. (Standard deviation for all samples was less than 2%; constant process conditions available in Table 2).
It would be expected that an increase in ADH concentration would yield a more active product. On the contrary, with an increase in enzyme concentration to 0.03 mg/mL and 0.04 mg/mL, the expressed activity of immobilized ADH-CMD-MNPs decreased gradually, while using all optimized conditions from previous steps, as for activation, (4% (v/v) EClH for 1 h at 300 rom and 20 °C) and for immobilization protocols (2 h at 4 °C, pH 7.5 and 500 rpm). When the ADH concentration was increased from 0.02 mg/mL to 0.03 mg/mL, the expressed activity decreased from 90 to 63%, and the immobilization yield decreased from 90 to 32%. With a further increase of ADH concentration to 0.04 mg/mL, the expressed activity decreased even more, to 42%, and the immobilization yield decreased slightly more, to 31%. These results can be observed in Fig. 3b. However, the decrease in expressed activity with increasing enzyme concentration can be attributed to the oversaturation of the enzyme over the support surface. Moreover, high enzyme concentration clustered on the surface of the support can reduce enzyme activity, owing to limited active site accessibility and denaturation of the enzyme114,115,116,117. Furthermore, the immobilization protocol might distort the enzyme, when there are multi-interactions between the enzyme and the support. In addition, the active center of the enzyme might become blocked by the immobilization protocol and promote diffusion problems. Such problems may lead to precipitation or aggregation of a soluble enzyme in the anhydrous medium. One solution to this problem is the preparation of a flexible and hydrophilic spacer arm that is long and flexible, which is similar to the soluble enzyme and has no ability to precipitate or aggregate. Also, immobilization might cause new interactions between the enzyme and the support, which could alter the conformation of the enzyme and its catalytic activity14.
While most research describes the improvement in ADH’s activity after immobilization via investigation of temperature and pH effect, our study investigates the effect of six different process parameters on the expressed activity of ADH. Temperature and pH of the immobilization medium, along with rotation speed, activating agent concentration, immobilization time and enzyme concentration were investigated, as well. Shakir et al. reported about ADH immobilization on nanocrystalline Ni–Co ferrites used as magnetic support, where expressed activity of the immobilized ADH was 70% at 45 °C and pH 890. Furthermore, ADH immobilized onto magnetic nanoparticles exhibited the highest expressed activity of 49% at 30 °C and pH 6.8 in research by Li et al.89. Another study by Li et al. describes the highest obtained expressed activity of 65% at pH 7.4 and 30 °C, where ADH was immobilized onto chitosan-coated MNPs44. Alam et al. investigated ADH immobilization on polyaniline-coated Ag nanoparticles, where the highest expressed activity of immobilized ADH was 73% at pH 8 and 40 °C91. Shinde et al. studied immobilization of ADH onto polyvinyl alcohol fibrous carriers, where immobilized ADH retained 60% of its original activity84. Research by Jiang et al. reports 92% expressed activity of immobilized ADH onto epoxy-functionalized silica MNPs at 30 °C and pH 8 after 12 h of immobilization63. All these reports show moderately high expressed activity of immobilized ADH on a range of carriers, but CMD-MNPs were not used in any of these studies. Our study presents the use of CMD-MNPs, which were epoxy-activated, as were the silica MNPs from the Jiang study63, where we also managed to obtain very high expressed activity of immobilized ADH-CMD-MNPs, a result of 90%. This is an important contribution to the improvement of the ADH immobilization process.
Properties of immobilized ADH-CMD-MNPs
Thermal stability of soluble ADH and immobilized ADH-CMD-MNPs
As is well known, soluble ADH is very unstable, although it is highly active85. Increasing the thermal stability of ADH by immobilization is very important to provide a wider spectrum of use for different applications. Thermal stability of immobilized ADH-CMD-MNPs was studied at 20 °C and 40 °C after 3 h and 24 h of incubation, compared to soluble ADH treated under the same conditions. After 3 h of incubation at 20 °C, expressed activity of immobilized ADH-CMD-MNPs was 79%, while the activity of soluble ADH was 83%. However, with prolongation of incubation time to 24 h, expressed activity of immobilized ADH-CMD-MNPs decreased to 68%, while soluble ADH exhibited only 28% of expressed activity. When incubating immobilized ADH-CMD-MNPs at 40 °C, its expressed activity after 3 h of incubation resulted in 126%, and when the incubation time was prolonged to 24 h, although the expressed activity of immobilized ADH-CMD-MNPs dropped to 80%, the enzyme was still found to be very stable. In the comparison, soluble ADH had very low enzyme activity at 40 °C after 3 h (19%) and was, as expected, inactive after 24 h of incubation at 40 °C. In addition, we investigated the expressed activity of soluble ADH after 5 h at 40 °C, and the enzyme was also found to be inactive. These results are presented in Fig. 4a and suggest that our immobilization protocol, using epoxy-activated CMD-MNPs as support for ADH managed to improve enzyme stability even after 24 h of incubation at 20 °C and 40 °C. The change in expressed activity of immobilized ADH-CMD-MNPs during incubation at 40 °C could also be attributed to a combination of a certain temperature and incubation time with epoxy-activated CMD-MNPs, which can cause a change in the catalytic capability of the enzyme114.
Thermal stability at 20 °C and 40 °C after 3 and 24 h (a), storage stability at 4 °C after 21 days (b) of immobilized ADH-CMD-MNPs and soluble ADH, reusability of immobilized ADH-CMD-MNPs after 18 consecutive cycles (c) and Lineweaver–Burk double reciprocal plot for soluble ADH and immobilized ADH-CMD-MNPs; substrate ethanol concentration was varied between 0.3 and 0.8 M for both soluble and immobilized ADH-CMD-MNPs (d). (Standard deviation for all samples was less than 2%).
Highly improved thermal stabilization of the immobilized ADH offers the opportunity to use this enzyme in a broader range of applications. A thermal study by Bolivar et al. reported less than 30% of expressed activity of immobilized ADH after 24 h at 63 °C88, while Li et al. reported 80% of expressed activity of immobilized ADH after just 1 h at 50 °C89. Moreover, Shinde et al. investigated the thermal stability of immobilized ADH after just 2 h at 60 °C and 80 °C, which resulted in 80% and 60% of expressed activity of immobilized ADH, respectively84. Jiang et al. reported 89% of expressed activity of immobilized ADH after 3 h at 50 °C63. Research studies by Shakir and Alam both report 5-h investigations of thermal stability, where Shakir et al. reported 45% of expressed activity of immobilized ADH onto CoFe2O4 MNPs and 66% of expressed activity of immobilized ADH onto NiFe2O4 MNPs, both of which were investigated at 60 °C90. However, Alam et al. reported 71% of expressed activity of immobilized ADH at 50 °C91. In comparison, our study yielded better thermal stability of immobilized ADH, since it retained 80% of its initial activity after 24 h at 40 °C, while soluble ADH was inactivated under the same conditions.
Storage stability of solube ADH and immobilized ADH-CMD-MNPs
Storage stability of immobilized ADH is another important factor for its application. To investigate storage stability, immobilized ADH-CMD-MNPs and soluble ADH were incubated at 4 °C for 21 days, and expressed activity was determined at certain time intervals, compared to the expressed activity of ADH-CMD-MNPs on day 1. The results are shown in Fig. 4b. After being placed at 4 °C, immobilized ADH-CMD-MNPs managed to maintain 82% of its expressed activity after 6 days, while soluble ADH lost more than 80% of its initial activity and maintained only 15% after 6 days. On day 8, expressed activity of immobilized ADH-CMD-MNPs decreased to 71%, while soluble ADH showed only 5%. After 14 days, the expressed activity of immobilized ADH-CMD-MNPs further decreased to 70%, while soluble ADH completely deactivated and lost all of its activity. After 16 days, immobilized ADH-CMD-MNPs still maintained 60% of the expressed activity. The activity drop was found to be linearly dependent on storage time, and immobilized ADH-CMD-MNPs maintained 60% of the expressed activity after 21 days at 4 °C. This confirms the very strong enzyme stabilization, since after 21 days of storage, the half-life of the immobilized enzyme was still not reached.
Reusability and half-life
Reusability is an important parameter that evaluates the yield of the immobilized enzyme and its usage on a large scale. Figure 4c shows the expressed activity of immobilized ADH used for 18 consecutive cycles, where it can be observed that immobilized ADH exhibited activity after 17 cycles and maintained more than 60% of initial activity even after 6 consecutive cycles. Half-life of immobilized ADH was reached after 8 cycles. This indicates that the immobilized ADH has good recovery, with minimum leakage and good durability.
Kinetic constant determination of soluble and immobilized ADH
In order to determine the KM of soluble and immobilized ADH, the peak area of the product for a series of concentrations of ethanol was determined (at 0.3 M, 0.4 M, 0.5 M, 0.6 M, 0.7 M to 0.8 M). According to Eq. (6), the linear regression obtained for soluble ADH was y = 105.68x + 846.08, and the KM value of soluble ADH was obtained from the slope and maximum reaction velocity, which was calculated and resulted in 125 mM, while vmax resulted in 1.2 µmol/min. The linear regression for immobilized ADH-CMD-MNPs was y = 15.359x + 209.25, and the KM value of immobilized ADH was obtained from the slope and maximum reaction velocity, as well, which was calculated, resulting in 73 mM, while vmax resulted in 4.7 µmol/min (Fig. 4d). The lower KM value of immobilized ADH indicates its higher affinity towards the substrate. The reason may lie in the smaller size of the CMD-MNPs prepared for ADH immobilization, which causes a decrease in steric hindrance of the nanoparticles, thus increasing the accessibility of active enzyme sites to the substrate63. With that, the lower KM value of our immobilized ADH indicates that our immobilization protocol improved ADH’s enzymatic performance, while improving its stability and potential for reusability. The lower KM confirms the improvement in immobilized ADH through our epoxy-activated immobilization protocol onto CMD-MNPs.
The comparison of enzyme properties using different immobilization protocols for ADH is shown in Table 1. ADH immobilized onto polyaniline-coated Ag nanoparticles and magnetic crystalline Ni–Co nanoferrites gave higher KM values of 205.3 mM and 237 mM, respectively. Moreover, the expressed activity of immobilized ADH was only 70% and 73%, respectively90,91. Other immobilization protocols which gave lower KM values used different chitosan- or silica-coated nanoparticles and resulted in 37.77 mM and 31.32 mM, respectively63,89. However, Li et al. managed to obtain only 49% expressed activity of immobilized ADH, which was lower than in our study89. As in our study, Jiang et al. also used epoxy-functionalized MNPs, and the KM value was low as well, resulting in 32.32 mM. The expressed activity of immobilized ADH was high, as in our study, resulting in 92%63. In addition, the investigation by Jiang et al. proves the good thermal stability of immobilized ADH, which resulted in 89% of expressed activity after just 3 h at 50 °C63, while our thermal stability study even improved those results, resulting in 126% of expressed activity after 3 h and in 80% of expressed activity after 24 h at 40 °C. Our study and the study by Jiang et al. prove the beneficial properties of MNPs being functionalized with highly active epoxy groups, which results in high expressed activity of immobilized ADH and in low KM values. The increase or decrease in KM values indicate that immobilized ADH has an apparent lower or higher affinity towards the substrate; in our case, lower KM value of immobilized ADH compared to soluble ADH shows an improvement brought by our immobilization protocol. Therefore, the immobilized ADH shows improved biocatalytic properties in possible applications. Compared to other carriers, epoxy-functionalized nanoparticles seem to be more suitable for immobilization of ADH, since epoxy groups of functionalized MNPs bind successfully with functional groups of ADH, and can therefore considerably improve ADH expressed activity after immobilization protocols.
Characterization of immobilized ADH-CMD-MNPs
After process of immobilizing ADH onto synthesized CMD-MNPs, characterization of the immobilized ADH-CMD-MNPs was performed, to obtain the structural properties of our CMD-MNP carrier with the immobilized enzyme. The presence of immobilized ADH onto CMD-MNPs was confirmed by FT-IR and TGA analysis, while the size and morphology of immobilized ADH-CMD-MNPs were investigated using SEM and DLS techniques.
FT-IR spectroscopic studies
The FT-IR spectra of CMD-MNPs, ADH-CMD-MNPs and soluble ADH presented in Fig. 5a were studied. The absorption peaks at 569 cm−1 and 682 cm−1 belong to the stretching vibration modes of the Fe–O bond, which indicate that the MNPs were successfully synthesized. Characteristic adsorption peaks are shown at 2900 cm−1 and 1375–1460 cm−1, and these belong to CMD νC–H and δC–H vibrational modes, while characteristic peak at 917 cm−1 belongs to α-glucopyranose ring98. The absorption peaks at 1010 cm−1 and 1250 cm−1 correspond to CMD νC–O vibrations118, while the broad absorption peak at 3408 cm-1 corresponds to the characteristic νO–H stretching and δO–H deformation modes of CMD hydroxyl groups, while CMD carboxyl groups are represented by the absorption peak at 1642–1730 cm−1. The ADH enzyme complex in ADH-CMD-MNPs shows characteristic absorption peaks at 1330 cm−1, 1641 cm−1 and 1450 cm−1, which can also be observed in the soluble ADH spectra, exhibiting characteristic frequencies of the ADH complex at 1641 cm−1 and 1388 cm−1. Furthermore, the symmetric ring stretching frequency of the epoxy ring around 831, 921, and 1249 cm−1 was presented119, indicating the existence of the epoxy group on epoxy-activated CMD-MNPs.
FT-IR spectra of soluble ADH, CMD-MNPs and ADH-CMD-MNPs (a), TGA curves (b), SEM images (c), zeta potential (d) and size distribution by intensity (e) of CMD-MNPs and ADH-CMD-MNPs; values are presented in a graph of three independent measurements for each sample.
Thermogravimetric analysis
The TGA of CMD-MNPs and ADH-CMD-MNPs is presented in Fig. 5b. TGA represents the change in mass, which is dependent on increasing temperature. The TGA curve of CMD-MNPs shows that initial weight loss pertains to the temperature range of 70–150 °C, which is due to the loss of physically adsorbed water. The second weight loss pertains to the temperature range of 150–300 °C. This is the temperature required to induce thermal degradation of polymers, which corresponds to decomposition of CMD. We can observe almost 40% mass loss of CMD-MNPs. The epoxy-activated ADH-CMD-MNPs begin degradation at a similar range of 70–150 °C, which also corresponds to the initial loss of adsorbed water. It can be observed that for epoxy-activated ADH-CMD-MNPs, degradation begins in the temperature range from 400–450 °C, which corresponds to the degradation temperature of epoxy-activated materials, which is around 440 °C. Our TGA study shows that at 600 °C, there is approx. 20% of mass loss detected, which indicates that immobilization of ADH via epoxy activation increases the thermal stability of ADH-CMD-MNPs120, as non-immobilized ADH would formulate to ash after 100 °C and CMD-MNPs lose 40% of its initial mass above 400 °C. This confirms the epoxy-activated structure of ADH-CMD-MNPs121,122.
SEM micrographs of CMD-MNPs and ADH-CMD-MNPs
The morphology of epoxy-activated CMD-MNPs with immobilized ADH was investigated by SEM. Figure 5c shows SEM images of CMD-MNPs without bound ADH (a) and epoxy activated CMD-MNPs with immobilized ADH. It is clear that CMD-MNPs and ADH-CMD-MNPs are spherical in shape and monodispersed. However, before immobilization of ADH, CMD-MNPs had a more uniform size, which was, on average, 28 nm, as investigated in and reported by our previous research106. After immobilization, it can be observed that CMD-MNPs are covered with a layer of enzyme due to epoxy activation, since such epoxy activation that is performed in a two-step mechanism allows ADH to covalently bind to CMD-MNPs. The sizes are slightly uneven and increased in diameter, ranging from 57 to 78 nm. Therefore, SEM images give additional confirmation that ADH has been successfully bound to the surface of CMD-MNPs by covalent attachment, resulting in the nano-sized product.
DLS analysis
The stability of the immobilized enzyme in the aqueous phase indicates an important influence on the potential for use, since most of reactions including enzymes are performed in the aqueous phase. Therefore, zeta potential was measured to indicate the stability of colloidal dispersion. The zeta potential of CMD-MNPs and immobilized ADH-CMD-MNPs was − 31.9 mV and − 26.8 mV, respectively (Fig. 5d). Both prepared CMD-MNPs and immobilized ADH-CMD-MNPs exhibit negative zeta potential, which indicates negatively charged hydroxyl and carboxyl groups of CMD present on the surface of nanoparticles. Zeta potential indicates that CMD-MNPs and ADH-CMD-MNPs show good dispersion in the aqueous phase.
In addition, the hydrodynamic size of the nanoparticles was measured and showed slightly larger (> 100 nm) nanoparticles. The results are presented in Fig. 5e. Differences in the particle size measured with DLS and other techniques (SEM or TEM) can occur because particle size measured by the DLS method represents the size of water-containing particles, which means that DLS measures the hydrodynamic radius of the nanoparticles. Also, magnetic nanoparticles tend to aggregate in order to reduce their surface energy. Many studies report a difference in their size obtained by SEM and DLS96,106,123,124.
The size distribution of nanoparticles is expressed in a polydispersity index (PdI). The PdI of ADH-CMD-MNPs is slightly higher (0.53), which is due to the layer of ADH immobilized on the surface of CMD-MNPs, which can also be observed from SEM images, while CMD-MNPs have a PdI of 0.31. Because ADH-CMD-MNPs are slightly uniform in size, the PdI index increases, as well.
Conclusions
CMD-MNPs were successfully activated with epoxy groups using the activating agent EClH for covalent immobilization of ADH via a two-step immobilization protocol onto epoxy-activated supports. This optimized immobilization protocol resulted in not only 90% of expressed activity of immobilized ADH, but also in very good thermal and storage stability, an outcome which gives high importance to this study. Results indicated that epoxy-activated CMD-MNPs are favourable for ADH immobilization, which offers an opportunity for use in various biological applications (in the production of chiral pharmaceutical intermediates or in the preparation of fine chemicals). It also offers the opportunity for sensitive and rapid determination of ethanol in biosensor technologies, based on selective ethanol-converting enzymes, such as ADH. In our future studies, we plan to further investigate the optimized biocatalyst, perform additional experiments regarding the operational nature of the biocatalyst and apply it in bioreactor research.
Methods
Materials
Iron (III) chloride hexahydrate (FeCl3∙6H2O), iron (II) chloride tetrahydrate (FeCl2∙4H2O) and Coomassie brilliant blue were obtained from Merck. Ammonium hydroxide was purchased from Chem-Lab, Belgium. CMD sodium salt, EClH (1-Chloro-2,3-epoxypropane), sodium pyrophosphate, sodium phosphate, ethanol, β-nicotinamide adenine dinucleotide (β-NAD) and ADH from S. cerevisiae were purchased from Sigma-Aldrich. All reagents in this work were of analytical purity and used without further purification. In all experiments, deionized water was used.
Synthesis of CMD-MNPs
CMD-MNPs were synthesized with co-precipitation of ferrous (Fe2+) and ferric (Fe3+) ions in a molar ratio 1:2. CMD was dissolved in distilled water with a final concentration of 0.5 g/mL. The solution of ferrous and ferric ions was mechanically stirred under N2 atmosphere at a temperature of 85 °C, and the CMD solution was added to the mixture. The mixture was precipitated drop-wise with an ammonia solution (NH4OH) and mechanically stirred for 1 h at 85 °C under N2 atmosphere. The obtained black precipitate was washed three times with distilled water and twice with ethanol. The preparation and synthesis of our CMD-MNPs with its detailed characterization analysis has already been published and is described in detail as CMD3-MNPs in106.
Immobilization of ADH onto CMD-MNPs via epoxy activation
20 mg of CMD-MNPs were activated with 0.5 M EClH in the presence of 10 mM sodium phosphate buffer (pH 7.5). The CMD-MNPs were incubated with EClH at specific volumetric ratios at 300 rpm for 1 h at room temperature (20 °C). After 1 h, the supernatant was removed and 7.4 U/mL of ADH and sodium phosphate buffer were added to the CMD-MNPs at 300 rpm for 2 h at room temperature (20 °C) to obtain ADH-CMD-MNPs. After immobilization, the ADH-CMD-MNPs were washed twice with distilled water and magnetically separated using a permanent magnet. Subsequently, activity assay for ADH and protein determination using the Bradford method were performed to determine the expressed activity and immobilization yield of ADH-CMD-MNPs. Our immobilization protocol followed a two-step mechanism of immobilizing enzyme ADH onto epoxy activated CMD-MNPs. In the first step, the enzyme ADH was physically adsorbed to epoxy activated CMD-MNPs, in the second step, the enzyme ADH was covalently attached to the epoxy groups present on the surface of CMD-MNPs. The overall idea and a schematic presentation of our immobilization protocol is presented in Fig. 6a.
Schematic presentation of a two-step mechanism of immobilizing enzyme ADH onto epoxy activated CMD-MNPs (a) and reaction scheme of ethanol oxidation and acetaldehyde reduction catalyzed by enzyme ADH (b).
Assay for ADH activity
The activity of soluble and immobilized ADH was determined spectrophotometrically, using ethanol as a substrate and is based on the following reaction, presented in Fig. 6b. The standard reaction mixture in a total volume of 3 mL contained 22 mM sodium pyrophosphate, 3.2% (v/v) ethanol, 7.5 mM β-NAD, 0.3 mM sodium phosphate, 0.003 (w/v) % BSA and 0.075 units of ADH. The reaction was initiated by the addition of ethanol and β-NAD to the soluble or immobilized ADH, and subsequently, the increase in absorbance at 340 nm due to the formation of β-NADH was measured in an incubation time of 6 min.
The activity of soluble and immobilized ADH was calculated using the following equation:
where: 3—total volume (mL) of assay, df—dilution factor, 6.22—millimolar extinction coefficient of β-NADH at 340 nm, 0.1—volume (mL) of enzyme used.
Enzymatic activity of ADH was measured in triplicate by enzymatic assay for ADH by the Sigma-Aldrich protocol125, and the expressed activity was calculated from the following equation:
Protein determination and immobilization yield calculation
The protein amount of non-immobilized and immobilized ADH was determined by measuring the protein concentration by the Bradford method, using Bovine serum albumin (BSA) as a standard126. The amount of ADH immobilized on the surface of the CMD-MNPs was determined in the supernatant fraction (cs) and later calculated by subtracting the measured amount (cs) from the amount of non-immobilized ADH (ce).
Immobilization yield was calculated using the following equation:
where: cs—protein concentration in supernatant fraction of immobilized ADH, ce—protein concentration of soluble ADH.
100% immobilization yield corresponds to the amount of immobilized enzyme of 0.1414 mg/mL.
All measurements for activity and protein determination were performed in triplicate and exhibited a standard deviation of less than 2%.
Effects of process parameters on ADH immobilization
Single-factor experiments were performed in order to study different immobilization conditions influencing the immobilization of ADH onto CMD-MNPs. Activating agent (EClH) concentration (2, 4, 6, 8% (v/v)), immobilization temperature (4 °C, 20 °C, 30 °C, 40 °C), rotation speed of immobilization process (200 rpm, 400 rpm, 500 rpm), pH of immobilization medium (5, 7, 7.5, 8, 9), time of immobilization (2 h, 3 h, 6 h, 12 h, 24 h) and enzyme concentrations (0.02 mg/mL, 0.03 mg/mL, 0.04 mg/mL) were applied to the immobilization process as variables. While optimizing each condition, previously optimized conditions always remained the same. Information on the constant process parameters during each optimization protocol is available in Table 2.
Properties of immobilized ADH-CMD-MNPs
Thermal stability
Thermal stability of immobilized ADH-CMD-MNPs was studied by measuring expressed activity of the immobilized ADH-CMD-MNPs after incubation at two different temperatures, 20 °C and 40 °C after 3 h, 5 h and 24 h in relation to expressed activity of immobilized ADH-CMD-MNPs before incubation. The calculation followed Eq. (4):
Storage stability
Storage stability of immobilized ADH-CMD-MNPs was studied by measuring expressed activity of immobilized ADH-CMD-MNPs at 4 °C for 22 days, with time intervals of a few days. Expressed activity was calculated according Eq. (5):
Reusability assay
The reusability assay of immobilized ADH was performed in triplicate by activity measurement at room temperature at time intervals of 30 min. After each activity assay, the immobilized assay was washed with 1 mL of 10 mM sodium phosphate buffer (pH 7.5) and magnetically separated. After 30 min, the next activity measurement was carried out and compared to the first run (activity defined as 100%).
Determination of KM and vmax for soluble and immobilized ADH
The enzyme kinetics parameters, Michaelis–Menten constant (KM) and maximum reaction velocity (vmax) are characteristic kinetic constants that are used to evaluate the performance of immobilized enzymes. Therefore, the kinetic parameters of soluble and immobilized ADH were determined. KM can be calculated using the Lineweaver–Burk diagram under optimum conditions127, following Eq. (6):
where: v—initial reaction velocity, vmax—maximum reaction velocity, [S]—substrate concentration, KM—Michaelis–Menten constant.
Six different concentrations of the substrate ethanol were selected (0.3 M, 0.4 M, 0.5 M, 0.6 M, 0.7 M and 0.8 M) and investigated under optimal condition processes, obtained during the research: 4% (v/v) EClH, pH 7.5, 4 °C, 500 rpm, 2 h of immobilization time and with 0.02 mg/mL of ADH. Different concentrations were analysed, and the peak area of the product was used to express the initial reaction velocity (v). The KM value of soluble and immobilized ADH was obtained by constructing the double reciprocal plot of 1/v versus 1/[S], based on Eq. (6).
Characterization of ADH-CMD-MNPs
Fourier transform infrared spectroscopy (FT-IR)
FT-IR spectra were recorded to study the chemical bonds formed between ADH immobilized CMD-MNPs. FT-IR analysis of the samples was performed by pressing the samples to form a tablet, using KBr as the matrix. The spectra were detected over a range of 4000–500 cm−1 and recorded by a FT-IR spectrophotometer (Perkin Elmer 1600 Fourier transform infrared spectroscopy spectrophotometer).
Thermogravimetric analysis (TGA)
TGA was performed on a TGA/DSC1 (Schimadzu, IRAffinity-1, Mettler Toledo, Switzerland) under N2 atmosphere, with a heating rate of 10 °C/min from room temperature to 600 °C. Temperature precision was ± 0.3 °C and temperature accuracy was ± 0.5 °C.
Scanning electron microscopy (SEM)
The morphology and size of CMD-MNPs and ADH-CMD-MNPs was investigated by SEM analysis, using a scanning electron microscope (FE, SEM SIRION, 400 NC, FEI). The samples were measured on a gold (Au) substrate.
Dynamic light scattering (DLS)
The particle size distribution, hydrodynamic size and ζ-potential of the samples were measured using DLS (Zetasizer Nano ZS). Each diameter value was the average of three consecutive measurements. Higher values indicate a very broad size distribution, whereas lower values correspond to more or less monodisperse particle size distributions. Measurement was carried out under equilibrium conditions. The measured samples were dispersed in water with neutral pH at room temperature. Concentrations of all CMD-MNPs and ADH-CMD-MNPs were 2 mg/mL.
Data availability
All data generated or analysed during this study are included in this published article.
References
Fernandez-Lafuente, R. Stabilization of multimeric enzymes: strategies to prevent subunit dissociation. Enzyme Microb. Technol. 45, 405–418 (2009).
Brady, D. & Jordaan, J. Advances in enzyme immobilisation. Biotechnol. Lett. 31, 1639–1650 (2009).
Mitchell, J. B. Enzyme function and its evolution. Curr. Opin. Struct. Biol. 47, 151–156 (2017).
Mateo, C., Palomo, J. M., Fernandez-Lorente, G., Guisan, J. M. & Fernandez-Lafuente, R. Improvement of enzyme activity, stability and selectivity via immobilization techniques. Enzyme Microb. Technol. 40, 1451–1463 (2007).
Zaak, H., Fernandez-Lopez, L., Otero, C., Sassi, M. & Fernandez-Lafuente, R. Improved stability of immobilized lipases via modification with polyethylenimine and glutaraldehyde. Enzyme Microb. Technol. 106, 67–74 (2017).
Fernandez-Lopez, L. et al. Effect of protein load on stability of immobilized enzymes. Enzyme Microb. Technol. 98, 18–25 (2017).
Pogorilyi, R. P., Melnyk, I. V., Zub, Y. L., Seisenbaeva, G. A. & Kessler, V. G. Enzyme immobilization on a nanoadsorbent for improved stability against heavy metal poisoning. Colloids Surf. B Biointerfaces 144, 135–142 (2016).
Zaak, H. et al. Effect of immobilization rate and enzyme crowding on enzyme stability under different conditions. The case of lipase from Thermomyces lanuginosus immobilized on octyl agarose beads. Process Biochem. 56, 117–123 (2017).
Zhu, J. & Sun, G. Lipase immobilization on glutaraldehyde-activated nanofibrous membranes for improved enzyme stabilities and activities. React. Funct. Polym. 72, 839–845 (2012).
Križnik, L., Vasić, K., Knez, Ž & Leitgeb, M. Hyper-activation of ß-galactosidase from Aspergillusoryzae via immobilization onto amino-silane and chitosan magnetic maghemite nanoparticles. J. Clean. Prod. 179, 225–234 (2018).
Primozic, M., Vasic, K., Kravanja, G., Knez, Z. & Leitgeb, M. Immobilized laccase for sustainable technological processes. Chem. Eng. Trans. 76, 91–96 (2019).
Hojnik Podrepšek, G., Knez, Ž & Leitgeb, M. Activation of cellulase cross-linked enzyme aggregates (CLEAs) in scCO2. J. Supercrit. Fluids 154, 1–9 (2019).
Wahab, R. A., Elias, N., Abdullah, F. & Ghoshal, S. K. On the taught new tricks of enzymes immobilization: an all-inclusive overview. React. Funct. Polym. 152, 104613 (2020).
Garcia-Galan, C., Berenguer-Murcia, Á., Fernandez-Lafuente, R. & Rodrigues, R. C. Potential of different enzyme immobilization strategies to improve enzyme performance. Adv. Synth. Catal. 353, 2885–2904 (2011).
Zdarta, J., Pinelo, M., Jesionowski, T. & Meyer, A. S. Upgrading of biomass monosaccharides by immobilized glucose dehydrogenase and xylose dehydrogenase. ChemCatChem 10, 5164–5173 (2018).
Zdarta, J., Meyer, A. S., Jesionowski, T. & Pinelo, M. Developments in support materials for immobilization of oxidoreductases: a comprehensive review. Adv. Colloid Interface Sci. 258, 1–20 (2018).
Zdarta, J., Meyer, A. S., Jesionowski, T. & Pinelo, M. A general overview of support materials for enzyme immobilization: characteristics, properties, practical utility. Catalysts 8, 92 (2018).
Zdarta, J., Meyer, A. S., Jesionowski, T. & Pinelo, M. Multi-faceted strategy based on enzyme immobilization with reactant adsorption and membrane technology for biocatalytic removal of pollutants: a critical review. Biotechnol. Adv. 37, 107401 (2019).
Mateo, C. et al. Advances in the design of new epoxy supports for enzyme immobilization–stabilization. Biochem. Soc. Trans. 35, 1593–1601 (2007).
Betancor, L. et al. Different mechanisms of protein immobilization on glutaraldehyde activated supports: Effect of support activation and immobilization conditions. Enzyme Microb. Technol. 39, 877–882 (2006).
Mateo, C. et al. Glyoxyl agarose: A fully inert and hydrophilic support for immobilization and high stabilization of proteins. Enzyme Microb. Technol. 39, 274–280 (2006).
Bilal, M., Asgher, M., Cheng, H., Yan, Y. & Iqbal, H. M. N. Multi-point enzyme immobilization, surface chemistry, and novel platforms: a paradigm shift in biocatalyst design. Crit. Rev. Biotechnol. 39, 202–219 (2019).
Cipolatti, E. P. et al. Nanomaterials for biocatalyst immobilization—state of the art and future trends. RSC Adv. 6, 104675–104692 (2016).
Cipolatti, E. P. et al. Current status and trends in enzymatic nanoimmobilization. J. Mol. Catal. B Enzym. 99, 56–67 (2014).
Barbosa, O. et al. Strategies for the one-step immobilization—purification of enzymes as industrial biocatalysts. Biotechnol. Adv. 33, 435–456 (2015).
Cipolatti, E. P., Manoel, E. A., Fernandez-Lafuente, R. & Freire, D. M. G. Support engineering: relation between development of new supports for immobilization of lipases and their applications. Biotechnol. Res. Innov. 1, 26–34 (2017).
Sirisha, V. L., Jain, A. & Jain, A. Enzyme immobilization: an overview on methods, support material, and applications of immobilized enzymes. Adv. Food Nutr. Res. 79, 179–211 (2016).
Hola, K., Markova, Z., Zoppellaro, G., Tucek, J. & Zboril, R. Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances. Biotechnol. Adv. 33, 1162–1176 (2015).
Tarvirdipour, S., Vasheghani-Farahani, E., Soleimani, M. & Bardania, H. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells. Int. J. Pharm. 501, 331–341 (2016).
Agiotis, L. et al. Magnetic manipulation of superparamagnetic nanoparticles in a microfluidic system for drug delivery applications. J. Magn. Magn. Mater. 401, 956–964 (2016).
Chertok, B., David, A. E. & Yang, V. C. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: Effect of administration route and magnetic field topography. J. Control. Release 155, 393–399 (2011).
Masood, F. Polymeric nanoparticles for targeted drug delivery system for cancer therapy. Mater. Sci. Eng. C 60, 569–578 (2016).
Kravanja, G., Primožič, M., Knez, Ž & Leitgeb, M. Chitosan-based (nano)materials for novel biomedical applications. Molecules 24, 1–23 (2019).
Jaime, J., Rangel, G., Muñoz-Bonilla, A., Mayoral, A. & Herrasti, P. Magnetite as a platform material in the detection of glucose, ethanol and cholesterol. Sens. Actuators B Chem. 238, 693–701 (2017).
Jędrzak, A. et al. Polydopamine grafted on an advanced Fe3O4/lignin hybrid material and its evaluation in biosensing. Appl. Surf. Sci. 455, 455–464 (2018).
Asmathunisha, N. & Kathiresan, K. A review on biosynthesis of nanoparticles by marine organisms. Colloids Surf. B Biointerfaces 103, 283–287 (2013).
Alcantara, D., Lopez, S., García-Martin, M. L. & Pozo, D. Iron oxide nanoparticles as magnetic relaxation switching (MRSw) sensors: current applications in nanomedicine. Nanomedicine Nanotechnol. Biol. Med. 12, 1253–1262 (2016).
Leitgeb, M. et al. Toxicity of magnetic chitosan micro and nanoparticles as carriers for biologically active substances. Acta Chim. Slov. 61, 145–152 (2014).
Liu, G., Gao, J., Ai, H. & Chen, X. Applications and potential toxicity of magnetic iron oxide nanoparticles. Small 9, 1533–1545 (2013).
Loh, J. W., Yeoh, G., Saunders, M. & Lim, L.-Y. Uptake and cytotoxicity of chitosan nanoparticles in human liver cells. Toxicol. Appl. Pharmacol. 249, 148–157 (2010).
Markides, H., Rotherham, M. & El Haj, A. J. Biocompatibility and toxicity of magnetic nanoparticles in regenerative medicine. J. Nanomater. 2012, 1–11 (2012).
Hauser, A. K., Mathias, R., Anderson, K. W. & Zach Hilt, J. The effects of synthesis method on the physical and chemical properties of dextran coated iron oxide nanoparticles. Mater. Chem. Phys. 160, 177–186 (2015).
Wei, Y. et al. Synthesis of Fe3O4 nanoparticles and their magnetic properties. Procedia Eng. 27, 632–637 (2012).
Li, G., Zhou, Z., Li, Y., Huang, K. & Zhong, M. Surface functionalization of chitosan-coated magnetic nanoparticles for covalent immobilization of yeast alcohol dehydrogenase from Saccharomycescerevisiae. J. Magn. Magn. Mater. 322, 3862–3868 (2010).
Barrera, C., Herrera, A., Zayas, Y. & Rinaldi, C. Surface modification of magnetite nanoparticles for biomedical applications. J. Magn. Magn. Mater. 321, 1397–1399 (2009).
Chen, H.-J., Zhang, Z.-H., Luo, L.-J. & Yao, S.-Z. Surface-imprinted chitosan-coated magnetic nanoparticles modified multi-walled carbon nanotubes biosensor for detection of bovine serum albumin. Sens. Actuators B Chem. 163, 76–83 (2012).
Hojnik Podrepšek, G. Synthesis comparison and characterization of chitosan-coated magnetic nanoparticles prepared with different methods. Mater. Technol. 48, 689–692 (2014).
Šulek, F., Drofenik, M., Habulin, M. & Knez, Ž. Surface functionalization of silica-coated magnetic nanoparticles for covalent attachment of cholesterol oxidase. J. Magn. Magn. Mater. 322, 179–185 (2010).
Banerjee, A. & Bandopadhyay, R. Use of dextran nanoparticle: a paradigm shift in bacterial exopolysaccharide based biomedical applications. Int. J. Biol. Macromol. 87, 295–301 (2016).
Easo, S. L. & Mohanan, P. V. Dextran stabilized iron oxide nanoparticles: synthesis, characterization and in vitro studies. Carbohydr. Polym. 92, 726–732 (2013).
Emami Meybodi, Z., Imani, M. & Atai, M. Kinetics of dextran crosslinking by epichlorohydrin: a rheometry and equilibrium swelling study. Carbohydr. Polym. 92, 1792–1798 (2013).
Tacias-Pascacio, V. G. et al. Dextran aldehyde in biocatalysis: more than a mere immobilization system. Catalysts 9, 622 (2019).
Shaterabadi, Z., Nabiyouni, G. & Soleymani, M. High impact of in situ dextran coating on biocompatibility, stability and magnetic properties of iron oxide nanoparticles. Mater. Sci. Eng. C 75, 947–956 (2017).
Mojica Pisciotti, M. L. et al. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting. J. Biomed. Mater. Res. B Appl. Biomater. 102, 860–868 (2014).
Borysov, A. et al. A comparative study of neurotoxic potential of synthesized polysaccharide-coated and native ferritin-based magnetic nanoparticles. Croat. Med. J. 55, 195–205 (2014).
Yu, M., Huang, S., Yu, K. J. & Clyne, A. M. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Int. J. Mol. Sci. 13, 5554–5570 (2012).
Mateo, C. et al. Epoxy-amino groups: a new tool for improved immobilization of proteins by the epoxy method. Biomacromol 4, 772–777 (2003).
Spinelli, D., Coppi, S., Basosi, R. & Pogni, R. Biosynthesis of ethyl butyrate with immobilized Candidarugosa lipase onto modified Eupergit®C. Biocatalysis 1, 1–12 (2014).
National Toxicology Program. Epichlorohydrin. Rep. Carcinog. Carcinog. Profiles 12, 180–183 (2011).
Hirakawa, B. Epichlorohydrin. In Encyclopedia of Toxicology 3rd edn (ed. Wexler, P.) 431–432 (Academic Press, London, 2014). https://doi.org/10.1016/B978-0-12-386454-3.00019-1.
Abraham, T. W. & Höfer, R. Lipid-based polymer building blocks and polymers. In Polymer Science: A Comprehensive Reference (eds Matyjaszewski, K. & Möller, M.) 15–58 (Elsevier, Amsterdam, 2012). https://doi.org/10.1016/B978-0-444-53349-4.00253-3.
Petkova, G. A., Záruba, K. & Král, V. Synthesis of silica particles and their application as supports for alcohol dehydrogenases and cofactor immobilizations: conformational changes that lead to switch in enzyme stereoselectivity. Biochim. Biophys. Acta BBA Proteins Proteomics 1824, 792–801 (2012).
Jiang, X.-P. et al. Immobilization of dehydrogenase onto epoxy-functionalized nanoparticles for synthesis of (R)-mandelic acid. Int. J. Biol. Macromol. 88, 9–17 (2016).
Lei, L. et al. Study on immobilization of lipase onto magnetic microspheres with epoxy groups. J. Magn. Magn. Mater. 321, 252–258 (2009).
Babaki, M., Yousefi, M., Habibi, Z., Brask, J. & Mohammadi, M. Preparation of highly reusable biocatalysts by immobilization of lipases on epoxy-functionalized silica for production of biodiesel from canola oil. Biochem. Eng. J. 101, 23–31 (2015).
Bayramoglu, G., Yilmaz, M. & Yakup Arica, M. Preparation and characterization of epoxy-functionalized magnetic chitosan beads: laccase immobilized for degradation of reactive dyes. Bioprocess Biosyst. Eng. 33, 439–448 (2010).
Forrest, G. L. & Gonzalez, B. Carbonyl reductase. Chem. Biol. Interact. 129, 21–40 (2000).
Oppermann, U. Carbonyl reductases: the complex relationships of mammalian carbonyl- and quinone-reducing enzymes and their role in physiology. Annu. Rev. Pharmacol. Toxicol. 47, 293–322 (2007).
Edenberg, H. J. & McClintick, J. N. Alcohol dehydrogenases, aldehyde dehydrogenases, and alcohol use disorders: a critical review. Alcohol Clin. Exp. Res. 42, 2281–2297 (2018).
Zhang, R., Xu, Y. & Xiao, R. Redesigning alcohol dehydrogenases/reductases for more efficient biosynthesis of enantiopure isomers. Biotechnol. Adv. 33, 1671–1684 (2015).
Wushur, I., Sylte, I. & Winberg, J.-O. The catalytic reaction mechanism of drosophilid alcohol dehydrogenases. Perspect. Sci. 4, 46–54 (2015).
Narayanan, K. B. & Sakthivel, N. Heterogeneous catalytic reduction of anthropogenic pollutant, 4-nitrophenol by silver-bionanocomposite using Cylindrocladiumfloridanum. Bioresour. Technol. 102, 10737–10740 (2011).
Sankar, R. et al. Origanum vulgare mediated biosynthesis of silver nanoparticles for its antibacterial and anticancer activity. Colloids Surf. B Biointerfaces 108, 80–84 (2013).
Mishra, A., Kaushik, N. K., Sardar, M. & Sahal, D. Evaluation of antiplasmodial activity of green synthesized silver nanoparticles. Colloids Surf. B Biointerfaces 111, 713–718 (2013).
Patel, R. N. Synthesis of chiral pharmaceutical intermediates by biocatalysis. Coord. Chem. Rev. 252, 659–701 (2008).
Breuer, M. et al. Industrial methods for the production of optically active intermediates. Angew. Chem. Int. Ed Engl. 43, 788–824 (2004).
Chien, P.-J. et al. Optical isopropanol biosensor using NADH-dependent secondary alcohol dehydrogenase (S-ADH). Talanta 159, 418–424 (2016).
Bilgi, M. & Ayranci, E. Biosensor application of screen-printed carbon electrodes modified with nanomaterials and a conducting polymer: ethanol biosensors based on alcohol dehydrogenase. Sens. Actuators B Chem. 237, 849–855 (2016).
Razumiene, J., Cirbaite, E., Razumas, V. & Laurinavicius, V. New mediators for biosensors based on PQQ-dependent alcohol dehydrogenases. Sens. Actuators B Chem. 207, 1019–1025 (2015).
Chien, P.-J. et al. Bio-sniffer (gas-phase biosensor) with secondary alcohol dehydrogenase (S-ADH) for determination of isopropanol in exhaled air as a potential volatile biomarker. Biosens. Bioelectron. 91, 341–346 (2017).
Dołęga, A. Alcohol dehydrogenase and its simple inorganic models. Coord. Chem. Rev. 254, 916–937 (2010).
Raj, S. B., Ramaswamy, S. & Plapp, B. V. Yeast alcohol dehydrogenase structure and catalysis. Biochemistry 53, 5791–5803 (2014).
Leskovac, V., Trivić, S. & Pericin, D. The three zinc-containing alcohol dehydrogenases from baker’s yeast, Saccharomycescerevisiae. FEMS Yeast Res. 2, 481–494 (2002).
Shinde, P., Musameh, M., Gao, Y., Robinson, A. J. & Kyratzis, I. Immobilization and stabilization of alcohol dehydrogenase on polyvinyl alcohol fibre. Biotechnol. Rep. 19, 1–7 (2018).
Bolivar, J. M., Rocha-Martín, J., Mateo, C. & Guisan, J. M. Stabilization of a highly active but unstable alcohol dehydrogenase from yeast using immobilization and post-immobilization techniques. Process Biochem. 47, 679–686 (2012).
de Smidt, O., du Preez, J. C. & Albertyn, J. The alcohol dehydrogenases of Saccharomycescerevisiae: a comprehensive review. FEMS Yeast Res. 8, 967–978 (2008).
Mateo, C. et al. Stabilization of multimeric enzymes via immobilization and further cross-linking with aldehyde-dextran. Methods Mol. Biol. Clifton NJ 2100, 175–187 (2020).
Bolivar, J. M. et al. Improvement of the stability of alcohol dehydrogenase by covalent immobilization on glyoxyl-agarose. J. Biotechnol. 125, 85–94 (2006).
Li, G. Y., Huang, K. L., Jiang, Y. R., Yang, D. L. & Ding, P. Preparation and characterization of Saccharomycescerevisiae alcohol dehydrogenase immobilized on magnetic nanoparticles. Int. J. Biol. Macromol. 42, 405–412 (2008).
Shakir, M. et al. Study on immobilization of yeast alcohol dehydrogenase on nanocrystalline Ni–Co ferrites as magnetic support. Int. J. Biol. Macromol. 72, 1196–1204 (2015).
Alam, M. F., Laskar, A. A., Zubair, M., Baig, U. & Younus, H. Immobilization of yeast alcohol dehydrogenase on polyaniline coated silver nanoparticles formed by green synthesis. J. Mol. Catal. B Enzym. 119, 78–84 (2015).
Jordan, A. et al. Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J. Magn. Magn. Mater. 194, 185–196 (1999).
Jung, C. W. & Jacobs, P. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: ferumoxides, ferumoxtran, ferumoxsil. Magn. Reson. Imaging 13, 661–674 (1995).
Linh, P. H. et al. Dextran coated magnetite high susceptibility nanoparticles for hyperthermia applications. J. Magn. Magn. Mater. 460, 128–136 (2018).
Molday, R. S. & Mackenzie, D. Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. J. Immunol. Methods 52, 353–367 (1982).
Remya, N. S., Syama, S., Sabareeswaran, A. & Mohanan, P. V. Toxicity, toxicokinetics and biodistribution of dextran stabilized iron oxide nanoparticles for biomedical applications. Int. J. Pharm. 511, 586–598 (2016).
Sudha, N., Yousuf, S., Israel, E. V. M. V., Paulraj, M. S. & Dhanaraj, P. On the accessibility of surface-bound drugs on magnetic nanoparticles. Encapsulation of drugs loaded on modified dextran-coated superparamagnetic iron oxide by β-cyclodextrin. Colloids Surf. B Biointerfaces 141, 423–428 (2016).
Ayala, V., Herrera, A. P., Latorre-Esteves, M., Torres-Lugo, M. & Rinaldi, C. Effect of surface charge on the colloidal stability and in vitro uptake of carboxymethyl dextran-coated iron oxide nanoparticles. J. Nanoparticle Res. 15, 1874–1898 (2013).
Creixell, M. et al. The effect of grafting method on the colloidal stability and in vitro cytotoxicity of carboxymethyl dextran coated magnetic nanoparticles. J. Mater. Chem. 20, 8539–8547 (2010).
Liong, M., Shao, H., Haun, J. B., Lee, H. & Weissleder, R. Carboxymethylated polyvinyl alcohol stabilizes doped ferrofluids for biological applications. Adv. Mater. 22, 5168–5172 (2010).
Liu, G., Hong, R. Y., Guo, L., Li, Y. G. & Li, H. Z. Preparation, characterization and MRI application of carboxymethyl dextran coated magnetic nanoparticles. Appl. Surf. Sci. 257, 6711–6717 (2011).
Wotschadlo, J. et al. Magnetic nanoparticles coated with carboxymethylated polysaccharide shells—interaction with human cells. J. Magn. Magn. Mater. 321, 1469–1473 (2009).
Dubrovsky, A. V., Musina, E. V., Kim, A. L. & Tikhonenko, S. A. Effect of polyelectrolytes on catalytic activity of alcohol dehydrogenase. Prikl. Biokhim. Mikrobiol. 52, 250–254 (2016).
Wilcox, A. E., LoConte, M. A. & Slade, K. M. Effects of macromolecular crowding on alcohol dehydrogenase activity are substrate-dependent. Biochemistry 55, 3550–3558 (2016).
Schneider, S. H. et al. Slowed diffusion and excluded volume both contribute to the effects of macromolecular crowding on alcohol dehydrogenase steady-state kinetics. Biochemistry 54, 5898–5906 (2015).
Vasić, K. et al. Structural and magnetic characteristics of carboxymethyl dextran coated magnetic nanoparticles: from characterization to immobilization application. React. Funct. Polym. 148, 1–13 (2020).
Buhus, G., Peptu, C., Popa, M. & Desbrieres, J. Controlled release of water soluble antibiotics by carboxymethylcellulose—and gelatin-based hydrogels crosslinked with epichlorohydrin. Cellul. Chem. Technol. 43, 141–151 (2009).
Chen, H., Zhang, Q., Dang, Y. & Guowei, S. The effect of glutaraldehyde cross-linking on the enzyme activity of immobilized β-galactosidase on chitosan bead. Adv. J. Food Sci. Technol. 5, 932–935 (2013).
Hamzah, A. et al. Effect of temperature and mixing speed on immobilization of crude enzyme from Aspergillus niger on chitosan for hydrolyzing cellulose. AIP Conf. Proc. 1840, 030006 (2017).
Harrington, T. J., Gainer, J. L. & Kirwan, D. J. Effects of fluid shear on immobilized enzyme kinetics. Enzyme Microb. Technol. 13, 610–616 (1991).
Munir, M. et al. Effects of high pressure, microwave and ultrasound processing on proteins and enzyme activity in dairy systems—a review. Innov. Food Sci. Emerg. Technol. 57, 1–14 (2019).
Zhao, Q. et al. Characterization of alcohol dehydrogenase from permeabilized brewer’s yeast cells immobilized on the derived attapulgite nanofibers. Appl. Biochem. Biotechnol. 160, 2287–2299 (2010).
Bayramoğlu, G., Kiralp, S., Yilmaz, M., Toppare, L. & Arıca, M. Y. Covalent immobilization of chloroperoxidase onto magnetic beads: catalytic properties and stability. Biochem. Eng. J. 38, 180–188 (2008).
Jiang, D.-S., Long, S.-Y., Huang, J., Xiao, H.-Y. & Zhou, J.-Y. Immobilization of Pycnoporussanguineus laccase on magnetic chitosan microspheres. Biochem. Eng. J. 25, 15–23 (2005).
Prousoontorn, M. H. & Pantatan, S. Production of 2-O-α-glucopyranosyl l-ascorbic acid from ascorbic acid and β-cyclodextrin using immobilized cyclodextrin glycosyltransferase. J. Incl. Phenom. Macrocycl. Chem. 57, 39–46 (2007).
Talbert, J. N. & Goddard, J. M. Enzymes on material surfaces. Colloids Surf. B Biointerfaces 93, 8–19 (2012).
Jamil, N. et al. Effect of enzyme concentration and temperature on the immobilization of cyclodextrin glucanotransferase (CGTase) on hollow fiber membrane. Mater. Today Proc. 5, 22036–22042 (2018).
Glišić, S., Nikolić, G., Cakić, M. & Trutić, N. Spectroscopic study of copper(II) complexes with carboxymethyl dextran and dextran sulfate. Russ. J. Phys. Chem. A 89, 1254–1262 (2015).
Nikolic, G. et al. Fast Fourier transform IR characterization of epoxy GY systems crosslinked with aliphatic and cycloaliphatic EH polyamine adducts. Sensors 10, 684–696 (2010).
Ye, X., Zeng, L. & Liu, T. Thermal stability and thermal degradation kinetic study of bismaleimide-epoxy modified novolac resin. Compos. Interfaces 19, 461–473 (2012).
Prabhu, T. N., Hemalatha, Y. J., Harish, V., Prashantha, K. & Iyengar, P. Thermal degradation of epoxy resin reinforced with polypropylene fibers. J. Appl. Polym. Sci. 104, 500–503 (2007).
Wu, C. S., Liu, Y. L., Chiu, Y. C. & Chiu, Y. S. Thermal stability of epoxy resins containing flame retardant components: an evaluation with thermogravimetric analysis. Polym. Degrad. Stab. 78, 41–48 (2002).
Barbosa-Barros, L., García-Jimeno, S. & Estelrich, J. Formation and characterization of biobased magnetic nanoparticles double coated with dextran and chitosan by layer-by-layer deposition. Colloids Surf. Physicochem. Eng. Asp. 450, 121–129 (2014).
Hradil, J., Pisarev, A., Babič, M. & Horák, D. Dextran-modified iron oxide nanoparticles. China Particuology 5, 162–168 (2007).
Kägi, J. H. & Vallee, B. L. The role of zinc in alcohol dehydrogenase. V. The effect of metal-binding agents on thestructure of the yeast alcohol dehydrogenase molecule. J. Biol. Chem. 235, 3188–3192 (1960).
Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254 (1976).
Sorouraddin, M.-H. et al. A new multi-wavelength model-based method for determination of enzyme kinetic parameters. J. Biosci. 35, 395–403 (2010).
Acknowledgements
The authors acknowledge the financial support of the Slovenian Research Agency, research core funding Nr. P2-0046—“Separation Processes and Product Design” and research core funding Nr. J2-1725—“Smart Materials for Bioapplications”.
Author information
Authors and Affiliations
Contributions
K.V. performed all of the experiments, performed data and statistical analysis, wrote the manuscript and designed the study together with M.L. M.L. reviewed and revised the manuscript. Ž.K. was responsible for the financial part of the project. All authors read and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Vasić, K., Knez, Ž. & Leitgeb, M. Immobilization of alcohol dehydrogenase from Saccharomyces cerevisiae onto carboxymethyl dextran-coated magnetic nanoparticles: a novel route for biocatalyst improvement via epoxy activation. Sci Rep 10, 19478 (2020). https://doi.org/10.1038/s41598-020-76463-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-020-76463-x
This article is cited by
-
Covalent Immobilization of Aspergillus niger Lipase on Epoxy-Activated Silver Oxide Nanoparticles-Impregnated Chitosan Surfaces: Characterization, Stability & Kinetic Studies
Catalysis Letters (2024)
-
Cloning, expression, and one-step purification/immobilization of two carbohydrate-binding module-tagged alcohol dehydrogenases
Journal of Biological Engineering (2022)
-
Nano-Biocatalysts: Potential Biotechnological Applications
Indian Journal of Microbiology (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
